{"name": "Tengion",
 "permalink": "tengion",
 "crunchbase_url": "http://www.crunchbase.com/company/tengion",
 "homepage_url": "http://www.tengion.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "610-292-8364",
 "description": "",
 "created_at": "Thu Mar 11 06:42:53 UTC 2010",
 "updated_at": "Fri Jul 02 20:23:53 UTC 2010",
 "overview": "\u003Cp\u003ETengion, a clinical-stage biotechnology company, is a leader in developing neo-organs and neo-tissues, currently derived from a patient\u0026#8217;s own (autologous) cells. The Company has completed two Phase 2 human clinical trial in the United States with its Tengion Neo-Bladder Augment\u00e2\u201e\u00a2 for children with neurogenic bladder due to spina bifida and in adults with neurogenic bladder due to spinal cord injury. A successful academic human clinical experience with a urinary Neo-Bladder Augment was reported in The Lancet in April 2006 by investigators from the Children\u0026#8217;s Hospital Boston. Tengion has an effective investigational new drug application (IND) for its Neo-Urinary Conduit\u00e2\u201e\u00a2 and expects to begin a Phase 1 clinical trial in the first half of 2010 in bladder cancer patients requiring bladder removal.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       31],
      "assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],
     [[250,
       52],
      "assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],
     [[289,
       61],
      "assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Business Development",
    "person":
     {"first_name": "Yousuf",
      "last_name": "Mazhar",
      "permalink": "yousuf-mazhar",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$122M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.tengion.com/news/press/20071015.cfm",
    "source_description": "Tengion Closes $33 Million in Series C Funding Deerfield Partners Joins Investor Group as Company Advances Novel Regenerative Medicine Products",
    "raised_amount": 33000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 10,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Deerfield Capital Management",
         "permalink": "deerfield-management",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/8515/58515v1-max-150x150.png"],
             [[250,
               43],
              "assets/images/resized/0005/8515/58515v1-max-250x250.png"],
             [[283,
               49],
              "assets/images/resized/0005/8515/58515v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bain Capital",
         "permalink": "bain-capital-2",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0007/2080/72080v1-max-150x150.png"],
             [[213,
               41],
              "assets/images/resized/0007/2080/72080v1-max-250x250.png"],
             [[213,
               41],
              "assets/images/resized/0007/2080/72080v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Oak Investment Partners",
         "permalink": "oak-investment-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0001/5086/15086v4-max-150x150.png"],
             [[193,
               78],
              "assets/images/resized/0001/5086/15086v4-max-250x250.png"],
             [[193,
               78],
              "assets/images/resized/0001/5086/15086v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L Capital Partners",
         "permalink": "l-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/9187/29187v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0002/9187/29187v1-max-250x250.png"],
             [[265,
               73],
              "assets/images/resized/0002/9187/29187v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Horizon Technology Finance Management LLC",
         "permalink": "horizon-technology-finance",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/5674/35674v2-max-150x150.png"],
             [[250,
               52],
              "assets/images/resized/0003/5674/35674v2-max-250x250.png"],
             [[259,
               54],
              "assets/images/resized/0003/5674/35674v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Oxford Finance Corporation",
         "permalink": "oxford-finance-corporation",
         "image":
          {"available_sizes":
            [[[114,
               150],
              "assets/images/resized/0006/0701/60701v2-max-150x150.jpg"],
             [[175,
               229],
              "assets/images/resized/0006/0701/60701v2-max-250x250.jpg"],
             [[175,
               229],
              "assets/images/resized/0006/0701/60701v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.tengion.com/news/press/20060623.cfm",
    "source_description": "Tengion Inc. Completes $50 Million Series \"B\" Round Financing led by Bain Capital and Quaker BioVentures will support neo-bladder clinical trials, manufacturing capacity and pipeline development",
    "raised_amount": 50000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 6,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Bain Capital",
         "permalink": "bain-capital-2",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0007/2080/72080v1-max-150x150.png"],
             [[213,
               41],
              "assets/images/resized/0007/2080/72080v1-max-250x250.png"],
             [[213,
               41],
              "assets/images/resized/0007/2080/72080v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Brookside Capital",
         "permalink": "brookside-capital",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0000/3991/3991v1-max-150x150.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-250x250.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Oak Investment Partners",
         "permalink": "oak-investment-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0001/5086/15086v4-max-150x150.png"],
             [[193,
               78],
              "assets/images/resized/0001/5086/15086v4-max-250x250.png"],
             [[193,
               78],
              "assets/images/resized/0001/5086/15086v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L Capital Partners",
         "permalink": "l-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/9187/29187v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0002/9187/29187v1-max-250x250.png"],
             [[265,
               73],
              "assets/images/resized/0002/9187/29187v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://phx.corporate-ir.net/phoenix.zhtml?c=218965\u0026p=irol-newsArticle\u0026ID=1431504\u0026highlight=",
    "source_description": "Tengion Inc. Completes $39 Million Series \"A\" Round Financing Will Advance Development of Regenerative Medicine Products",
    "raised_amount": 39000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 8,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Oak Investment Partners",
         "permalink": "oak-investment-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0001/5086/15086v4-max-150x150.png"],
             [[193,
               78],
              "assets/images/resized/0001/5086/15086v4-max-250x250.png"],
             [[193,
               78],
              "assets/images/resized/0001/5086/15086v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L Capital Partners",
         "permalink": "l-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/9187/29187v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0002/9187/29187v1-max-250x250.png"],
             [[265,
               73],
              "assets/images/resized/0002/9187/29187v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2900 Potshop Lane",
    "address2": "Suite 100",
    "zip_code": "19403",
    "city": "East Norriton",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2010,
   "pub_month": 4,
   "pub_day": 9,
   "stock_symbol": "NASDAQ:TNGN"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        114],
       "assets/images/resized/0007/9907/79907v1-max-150x150.jpg"],
      [[250,
        190],
       "assets/images/resized/0007/9907/79907v1-max-250x250.jpg"],
      [[450,
        342],
       "assets/images/resized/0007/9907/79907v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}